Xiaoling Liu1*, Zijian Yang1, Guangxin Li1, Sameh Yousef2 and Wei Wei1
1Department of Breast and Thyroid Surgery, Peking University Shenzhen Hospital, China
2Department of Surgery, Yale University School of Medicine, USA
A 40-year-old female was diagnosed with left breast ductal carcinoma in-situ by Core Needle Biopsy (CNB) and underwent breast conserving surgery and sentinel lymph node biopsy. Final pathology reported invasive carcinoma, no special type, grade III, triple negative subtype. She started postoperative chemotherapy 2 weeks after surgery and received 4 cycles of epirubicin plus
Cyclophosphamide, followed by 2 cycles of Docetaxel. The sixth chemo cycle was postponed for more than one month because of the outbreak of COVID-19. After her sixth cycle of chemotherapy, she underwent breast ultrasound and was found to have a new lesion in the ipsilateral breast. Vacuumassisted biopsy of the lesion confirmed recurrence of breast cancer in an Intramammary Lymph Node (IMLN) and she underwent completion mastectomy. Chemotherapy regimen was changed to Vinorelbine in combination with Capecitabine due to primary resistance to anthracyclines and Docetaxel. Radiotherapy was also arranged for her.
Breast cancer; Breast conserving surgery; Recurrence; Intramammary lymph node; Sentinel lymph node
Liu X, Yang Z, Li G, Yousef S, Wei W. Regional Recurrence of Breast Cancer in Ipsilateral Intramammary Lymph Node Six Months after Breast Conserving Surgery. Clin Oncol. 2020;5:1750..